This distinctive system induces a synergistic impact with Increased insulin reaction and glucagonostatic activity, versus GIP or GLP-1 therapy alone.Summary Tirzepatide is a different molecule able to managing glucose blood stages by combining the twin agonism of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-on